Literature DB >> 16785119

The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop review: assays and detection.

C Shone1, J Ferreira, A Boyer, N Cirino, C Egan, E Evans, J Kools, S Sharma.   

Abstract

The development of diagnostic tests for the botulinum neurotoxins is complicated by their extremely high potencies and the considerable diversity observed within the neurotoxin family. Current approaches for the detection of the toxins and the organism include amplified immunoassays and PCR techniques. Assays which exploit the biological activities within the botulinum toxins are also in development. These are based on both antibody and mass spectrometric techniques which measure the endopeptidase activities of the neurotoxins. This overview of the Assays and Detection Workshop of the 5th International Conference of on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins discusses recent progress in the development of these assay systems and the issues that need to be overcome prior to their implementation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785119     DOI: 10.1007/bf03033940

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  22 in total

1.  Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay.

Authors:  M Wictome; K Newton; K Jameson; B Hallis; P Dunnigan; E Mackay; S Clarke; R Taylor; J Gaze; K Foster; C Shone
Journal:  Appl Environ Microbiol       Date:  1999-09       Impact factor: 4.792

2.  Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics.

Authors:  Suzanne R Kalb; Michael C Goodnough; Carl J Malizio; James L Pirkle; John R Barr
Journal:  Anal Chem       Date:  2005-10-01       Impact factor: 6.986

3.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  Botulinum neurotoxins: mode of action and detection.

Authors:  M Wictome; C C Shone
Journal:  Symp Ser Soc Appl Microbiol       Date:  1998

5.  Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.

Authors:  B Hallis; B A James; C C Shone
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

6.  Interference of sugars with the binding of biotin to streptavidin and avidin.

Authors:  G Houen; K Hansen
Journal:  J Immunol Methods       Date:  1997-12-29       Impact factor: 2.303

7.  Rapid, quantitative PCR monitoring of growth of Clostridium botulinum type E in modified-atmosphere-packaged fish.

Authors:  B Kimura; S Kawasaki; H Nakano; T Fujii
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

8.  Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: collaborative study.

Authors:  Joseph L Ferreira; Susan Maslanka; Eric Johnson; Mike Goodnough
Journal:  J AOAC Int       Date:  2003 Mar-Apr       Impact factor: 1.913

9.  Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences.

Authors:  R A Hutson; Y Zhou; M D Collins; E A Johnson; C L Hatheway; H Sugiyama
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

Review 10.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

View more
  4 in total

Review 1.  Botulinum neurotoxin - from laboratory to bedside.

Authors:  K A Foster; H Bigalke; K R Aoki
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 2.  Botulinum neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

3.  Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan.

Authors:  Kaoru Umeda; Yoshiyuki Seto; Tomoko Kohda; Masafumi Mukamoto; Shunji Kozaki
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

4.  Hypersensitive detection and quantitation of BoNT/A by IgY antibody against substrate linear-peptide.

Authors:  Tao Li; Hao Liu; Kun Cai; Maoren Tian; Qin Wang; Jing Shi; Xiang Gao; Hui Wang
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.